Unit

Vogtle Unit 4 reaches initial criticality

Retrieved on: 
Wednesday, February 14, 2024

ATLANTA, Feb. 14, 2024 /PRNewswire/ -- Georgia Power announced today that Unit 4 at the Vogtle nuclear expansion project near Waynesboro, Georgia, has safely reached initial criticality. Initial criticality is a key step during the startup testing sequence and demonstrates that -- for the first time -- operators have safely started the nuclear reaction inside the second reactor. This means atoms are being split and nuclear heat is being made, which will be used to produce steam. 

Key Points: 
  • ATLANTA, Feb. 14, 2024 /PRNewswire/ -- Georgia Power announced today that Unit 4 at the Vogtle nuclear expansion project near Waynesboro, Georgia, has safely reached initial criticality.
  • Initial criticality is a key step during the startup testing sequence and demonstrates that -- for the first time -- operators have safely started the nuclear reaction inside the second reactor.
  • Achieving initial criticality is necessary to continue the startup of the unit in order to generate sufficient heat for the production of electricity.
  • Vogtle Unit 3 entered commercial operation on July 31, 2023, ( read more ) and is providing safe, reliable, emission-free energy to Georgia today.

Zacatecas Silver Closes $2.5 Million Financing

Retrieved on: 
Tuesday, February 13, 2024

VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”, ZAC:TSX Venture; ZCTSF: OTC Markets; 7TV: Frankfurt) announces that due to strong interest it has closed its previously announced private placement financing (see news releases dated January 29, 2024 and February 5, 2024) by issuing 25,000,000 units at a price of $0.10 per Unit for total proceeds of $2,500,000 (the “Offering”).

Key Points: 
  • VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”, ZAC:TSX Venture; ZCTSF: OTC Markets; 7TV: Frankfurt) announces that due to strong interest it has closed its previously announced private placement financing (see news releases dated January 29, 2024 and February 5, 2024) by issuing 25,000,000 units at a price of $0.10 per Unit for total proceeds of $2,500,000 (the “Offering”).
  • Each Unit consists of one common share (each, a “Common Share”); and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”).
  • The securities under the Offering will be subject to restrictions on resale expiring on June 14, 2024.
  • (Hons), PhD, FAusIMM (CP), FSEG, FGS, Chief Operating Officer of Zacatecas Silver.

Cosa Announces Upsized C$6.5 Million Bought Deal Private Placement to Fund Athabasca Basin Uranium Exploration

Retrieved on: 
Tuesday, February 13, 2024

VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cosa Resources Corp. (TSX-V: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa” or the “Company”) is pleased to announce that, in connection with its previously announced bought deal private placement offering (the “Offering”), it has entered into an amended agreement with Haywood Securities Inc., on behalf of itself and a syndicate of underwriters (collectively, the “Underwriters”) to increase the size of the Offering to: (i) 2,128,000 hard dollar units of the Company (the “Hard Dollar Units”) at a price of C$0.47 per Hard Dollar Unit (the “Hard Dollar Issue Price”), and (ii) 7,704,000 charity flow-through units of the Company (the “Charity FT Units”, and together with the Hard Dollar Units, the “Units”) at a price of C$0.714 per Charity FT Unit (the “Charity FT Issue Price”), for aggregate gross proceeds to the Company of C$6,500,816.

Key Points: 
  • Each Warrant will entitle the holder thereof to purchase one Share (a “Warrant Share”) at an exercise price of C$0.67 for 24 months following the completion of the Offering.
  • All Qualifying Expenditures will be renounced in favour of the subscribers of the Charity FT Units effective December 31, 2024.
  • The net proceeds from the sale of Hard Dollar Units will be used to fund exploration and for additional working capital purposes.
  • Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

SONORO GOLD ANNOUNCES REVISED $1 MILLION PRIVATE PLACEMENT

Retrieved on: 
Tuesday, February 13, 2024

VANCOUVER, Canada, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) announces it has revised the pricing of its previously announced non-brokered private placement offering (the "Offering"). The offering will now consist of up to 20,000,000 units (the “Units”) at a price of C$0.05 per Unit, for gross proceeds of up to C$1,000,000.  

Key Points: 
  • “THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION
    VANCOUVER, Canada, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) announces it has revised the pricing of its previously announced non-brokered private placement offering (the "Offering").
  • The offering will now consist of up to 20,000,000 units (the “Units”) at a price of C$0.05 per Unit, for gross proceeds of up to C$1,000,000.
  • Each Unit will be composed of one Sonoro common share and one common share purchase warrant.
  • Each warrant will entitle the holder thereof to purchase one additional Sonoro common share for a period of three years from the closing of the private placement at an exercise price of C$0.07 per share.

Rugby Resources Ltd. Announces an Increase in its Non-brokered Private Placement

Retrieved on: 
Monday, February 12, 2024

Vancouver, B.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Rugby Resources Ltd. (“Rugby” or the “Company”) (TSX-V: RUG) announces that due to subscriber demand, its board of directors has approved an increase to its private placement offering. The increased offering will consist of up to 19,666,666 units (the “Units”), up from the 8,333,333 Units previously announced on February 7, 2024. The terms of the private placement financing will remain the same and each Unit will be offered at a price of $0.06 per Unit for gross proceeds of $1,180,000 (the “Offering”).

Key Points: 
  • Vancouver, B.C., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Rugby Resources Ltd. (“Rugby” or the “Company”) (TSX-V: RUG) announces that due to subscriber demand, its board of directors has approved an increase to its private placement offering.
  • The increased offering will consist of up to 19,666,666 units (the “Units”), up from the 8,333,333 Units previously announced on February 7, 2024.
  • The terms of the private placement financing will remain the same and each Unit will be offered at a price of $0.06 per Unit for gross proceeds of $1,180,000 (the “Offering”).
  • For additional information you are invited to visit the Rugby Resources Ltd. website at www.rugbyresourcesltd.com
    Suite 1890 – 1075 West Georgia St.

BIOVAXYS ANNOUNCES COMPLETION OF FINAL TRANCHE OF PRIVATE PLACEMENT

Retrieved on: 
Saturday, February 10, 2024

VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the final tranche of a non-brokered private placement (the "Private Placement") consisting of 16,716,666 ("Units") at a price of $0.03 per Unit for total gross proceeds of $501,500.

Key Points: 
  • VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the final tranche of a non-brokered private placement (the "Private Placement") consisting of 16,716,666 ("Units") at a price of $0.03 per Unit for total gross proceeds of $501,500.
  • Each Unit consists of one common share (a "Common Share") and one whole Common Share purchase warrant (a "Warrant").
  • The Company intends to use the net proceeds of the Private Placement for working capital purposes.
  • The Company will pay a finder's fee of $16,976 in cash related to the final tranche of the financing.

BIOVAXYS ANNOUNCES COMPLETION OF FINAL TRANCHE OF PRIVATE PLACEMENT

Retrieved on: 
Saturday, February 10, 2024

VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the final tranche of a non-brokered private placement (the "Private Placement") consisting of 16,716,666 ("Units") at a price of $0.03 per Unit for total gross proceeds of $501,500.

Key Points: 
  • VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the final tranche of a non-brokered private placement (the "Private Placement") consisting of 16,716,666 ("Units") at a price of $0.03 per Unit for total gross proceeds of $501,500.
  • Each Unit consists of one common share (a "Common Share") and one whole Common Share purchase warrant (a "Warrant").
  • The Company intends to use the net proceeds of the Private Placement for working capital purposes.
  • The Company will pay a finder's fee of $16,976 in cash related to the final tranche of the financing.

BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

Retrieved on: 
Saturday, February 10, 2024

VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.

Key Points: 
  • VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.
  • Each Unit consists of one common share (a "Common Share") and one whole Common Share purchase warrant (a "Warrant").
  • The Company intends to use the net proceeds of the Private Placement for working capital purposes.
  • The Company anticipates closing the second and final tranche of the private placement no later than February 9th, 2024.

BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

Retrieved on: 
Saturday, February 10, 2024

VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.

Key Points: 
  • VANCOUVER, BC, Feb. 9, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.
  • Each Unit consists of one common share (a "Common Share") and one whole Common Share purchase warrant (a "Warrant").
  • The Company intends to use the net proceeds of the Private Placement for working capital purposes.
  • The Company anticipates closing the second and final tranche of the private placement no later than February 9th, 2024.

MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million

Retrieved on: 
Friday, February 9, 2024

Pursuant to the Offering, a total of 6,994,887 Units were sold at a price per Unit of $0.20 (the “Offering Price”).

Key Points: 
  • Pursuant to the Offering, a total of 6,994,887 Units were sold at a price per Unit of $0.20 (the “Offering Price”).
  • Each Unit consists of one common share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole warrant, a “Warrant”).
  • The Offering has been conducted pursuant to the listed issuer financing exemption from prospectus requirements in Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106").
  • The Units, the Warrants and the Warrant Shares are not subject to resale restrictions pursuant to applicable Canadian securities laws.